Multispecific antibodies against CD40 and CD137
US11440966B2 · kind B2 · utility
2Cited by
2References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2021 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Jun 11, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.